ESMO Supporter 2018

Displaying One Session

ICM - Room 5 Patient Advocacy Track
Date
19.10.2018
Time
16:00 - 17:30
Location
ICM - Room 5
Chairs
  • John B. Haanen (Amsterdam, NL)
  • Bettina Ryll (Uppsala, SE)
Immune therapies going adjuvant: Benefits versus risks Patient Advocacy Track

Introduction

Lecture Time
16:00 - 16:20
Speakers
  • Bettina Ryll (Uppsala, SE)
Location
ICM - Room 5, ICM München, Munich, Germany
Date
19.10.2018
Time
16:00 - 17:30
Immune therapies going adjuvant: Benefits versus risks Patient Advocacy Track

How long should we treat patients?

Lecture Time
16:20 - 16:40
Speakers
  • John B. Haanen (Amsterdam, NL)
Location
ICM - Room 5, ICM München, Munich, Germany
Date
19.10.2018
Time
16:00 - 17:30
Immune therapies going adjuvant: Benefits versus risks Patient Advocacy Track

Side effects

Lecture Time
16:40 - 17:00
Speakers
  • James Larkin (London, GB)
Location
ICM - Room 5, ICM München, Munich, Germany
Date
19.10.2018
Time
16:00 - 17:30
Immune therapies going adjuvant: Benefits versus risks Patient Advocacy Track

Q&A

Lecture Time
17:00 - 17:30
Location
ICM - Room 5, ICM München, Munich, Germany
Date
19.10.2018
Time
16:00 - 17:30